StockData
Novartis AG logo

Novartis AG

NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Feb 4, 2026Score 7/30
$160.79−0.31 (-0.19%)

Close on Oct 30, 2026Market cap $306.81BP/E 22.5Yield –

Novartis Canada and Latin America by Quarter

Canada and Latin America ($M)

QuarterlyAnnual

Novartis Canada and Latin America: $952M in Q3 2026, down 0.4% from a year earlier.

Latest, Q3 2026
952
Period ended Sep 30, 2026
Change on a year earlier
-0.4%
956 in Q3 2025
History
30 quarters
Since Q2 2019
Sources
26
Documents cited below

Where the Q3 2026 figure comes from

“|| Canada and Latin America | 952 | 956 | 0 | – 6 | 6 | 7”

Source: Novartis Form 6-K (0001114448-26-000014) ↗

Reported in Form 6-K & Form 20-F.

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedCanada and Latin America ($M)Year on yearSource
Q3 2026Sep 30, 2026952-0.4%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2026Jun 30, 2026995+7.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2026Mar 31, 2026948+12.3%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2025Dec 31, 2025953+8.8%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2025Sep 30, 2025956+4.5%Novartis Form 6-K (0001114448-26-000014) ↗
Q2 2025Jun 30, 2025922+1.9%Novartis Form 6-K (0001114448-26-000012) ↗
Q1 2025Mar 31, 2025844-5.9%Novartis Form 6-K (0001114448-26-000010) ↗
Q4 2024Dec 31, 2024876+22.9%Novartis Form 6-K (0001114448-26-000007) ↗
Q3 2024Sep 30, 2024915+7.0%Novartis Form 6-K (0001114448-25-000003) ↗
Q2 2024Jun 30, 2024905+9.6%Novartis Form 6-K (0001370368-25-000012) ↗
Q1 2024Mar 31, 2024897+14.7%Novartis Form 6-K (0001370368-25-000010) ↗
Q4 2023Dec 31, 2023713-2.2%Novartis Form 6-K (0001370368-25-000007) ↗
Q3 2023Sep 30, 2023855+15.1%Novartis Form 6-K (0001370368-24-000022) ↗
Q2 2023Jun 30, 2023826-57.6%Novartis Form 6-K (0001370368-24-000019) ↗
Q1 2023Mar 31, 2023782-17.8%Novartis Form 6-K (0001370368-24-000017) ↗
Q4 2022Dec 31, 2022729-80.0%Novartis Form 6-K (0001370368-24-000007) ↗

Breakdown

What makes up canada and Latin America

Cite this data

StockData. (2026). Novartis Canada and Latin America ($M), quarterly Q2 2019–Q3 2026 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/geo-canada-latam

See every metric in the Novartis KPI table. Data updated Nov 2, 2026.